Boston Scientific announced, on the 6 March 2013 the launch of its 0.035″ and 0.018″ Rubicon Support Catheter in the USA. The device is designed to assist physicians with placement and support of guidewires that are used in peripheral vascular procedures to deliver stents and balloons to open blockages in the legs and other peripheral arteries. Boston Scientific is also launching the 0.035″ Rubicon Support Catheter in Europe after the launch of the 0.018″ size that was introduced in that region last autumn.
“The Rubicon Support Catheter offers an outstanding combination of features,” said Louis Lopez, St Joseph’s Hospital, USA. “It offers the pushability, low-profile and flexibility needed for navigating through the types of challenging, complex lesions that physicians face in the peripheral vascular space.”
The Rubicon Support Catheter had previously been available in a 0.014″ diameter only, and the launch of the 0.035 and 0.018″ and sizes, according to the company, Boston Scientific now offers physicians a full range of diameters to treat patients with peripheral arterial disease. The Rubicon Support Catheter is also available in a variety of lengths including 65cm, 90cm, 135cm and 150cm.
“Support catheters can help physicians treat more patients by facilitating the crossing of complex lesions,” said Jeff Mirviss, president, Peripheral Interventions, Boston Scientific. “By making a full range of diameters of Rubicon Support Catheters available, we are offering more choices to clinicians. The Rubicon Support Catheter is one of many new solutions that Boston Scientific has introduced to the market during the past two years and demonstrates our continued commitment to global leadership in Peripheral Intervention.”
The Rubicon Support Catheter has received FDA 510(k) clearance and achieved CE Mark status.